Novavax to Present at the 37th Annual J.P. Morgan Healthcare Conference

Udgivet den 02-01-2019  |  kl. 21:05  |  

GAITHERSBURG, Md., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it will present at the 37th Annual J.P. Morgan Healthcare Conference.

Presentation details are as follows:

Date and time: Wednesday, January 9, 3:00 p.m. - 3:25 p.m. P.T.
Location: Colonial Room, Westin St. Francis Hotel, San Francisco
Live webcast: www.novavax.com, "Investors"/"Events"

A replay of the presentation will also be accessible under the "Investors/Events" section of the website at www.novavax.com.

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a late-stage biotechnology company that drives improved health globally through the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases. ResVax™, its RSV vaccine for infants via maternal immunization, is the only vaccine in a Phase 3 clinical program and is designed to prevent the second leading cause of death in children under one year of age worldwide. Novavax is also advancing NanoFlu™, its quadrivalent influenza nanoparticle vaccine, to address key factors that can lead to the poor effectiveness of currently approved flu vaccines. Novavax is a leading innovator of recombinant vaccines; its proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce a new class of highly immunogenic nanoparticles addressing urgent global health needs.

For more information, visit www.novavax.com and connect with us on Twitter and LinkedIn.

Contacts:

Investors
Novavax, Inc.
Erika Trahan
ir@novavax.com
240-268-2000

Westwicke Partners
John Woolford
john.woolford@westwicke.com
443-213-0506

Media
Sam Brown
Andrea Cohen
andreacohen@sambrown.com
917-209-7163

\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

09:19 Aktier/åbning: Unibrew på himmelflugt i konfliktfokuseret marked
09:06 Mærsk kan se rateindeks for containerfragt stige for tredje uge i træk
09:05 Obligationer/åbning: Beskedent rentefald efter missilangreb på Iran
08:26 Aktier/tendens: Unibrew og Mærsk kan gå mod strømmen i ventet rød åbning
08:03 GN får sat kursmålet op af Danske Bank der spår pæn organisk vækst i første kvartal
08:02 Unibrews opjustering ses belønnet med kursstigning på 2-5 pct. hos Jyske Bank
08:00 Antallet af folkepensionister steg i 2023
07:51 Unibrew får hævet anbefaling og kursmål hos ABG efter regnskab med opjustering
07:22 Fransk ISS-konkurrent leverer stærkere end ventet vækst drevet af højere priser
07:12 Israels angreb på Iran udløser markant prishop på olie
07:06 Obligationer/tendens: Udsigt til rentefald efter eskalering af konflikt i Mellemøsten
06:42 Sådan går det Mærsks asiatiske peers fredag
06:41 Asien: Massiv risikoaversion sender aktieindeks ud i solide kursfald
06:34 Netflix slog klart markedets forventninger i første kvartal - men aktien faldt
06:34 Iran lukker landets største lufthavn efter melding om angreb
06:34 Israelske missiler rammer Iran - medie
06:34 Demant-chef ser mere aktive ældre løfte markedet i USA
06:34 Demant-chef: Stigende tilskud har hjulpet markedet i USA - men ikke som i Europa
06:34 Unibrew-opjusterer indikerer at værste er ovre mener analytikere
06:34 Unibrew med stærkt momentum fra årets start - slår forventningerne